发明名称 Heteroarylcarbamoylbenzene derivatives
摘要 Compounds having glucokinase activating effects and being useful as treatments for diabetes, which are represented by the following formula (I): [wherein X1 represents oxygen, etc., X2 represents oxygen, etc., R1 represents a group on Ring A such as alkylsulfonyl, etc., R2 represents C3-7 cyclic alkyl optionally substituted with a halogen, etc., R3 represents a substituent on Ring B such as lower alkyl, etc., formula (II): [Chemical Formula 1] represents 6- to 10-membered aryl, etc., and formula (III): [Formula 1] represents monocyclic or bicyclic heteroaryl optionally having on Ring B a substituent represented by R3 above, wherein the carbon atom of Ring B which is bonded to the nitrogen atom of the amide group of formula (I) forms a C═N bond with the nitrogen atom of the ring], as well as their pharmaceutically acceptable salts.
申请公布号 US7754743(B2) 申请公布日期 2010.07.13
申请号 US20080231856 申请日期 2008.09.05
申请人 BANYU PHARMACEUTICAL CO., LTD. 发明人 IINO TOMOHARU;HASHIMOTO NORIAKI;NAKASHIMA HIROSHI;TAKAHASHI KEIJI;NISHIMURA TERUYUKI;EIKI JUN-ICHI
分类号 A61K31/44;A61K31/425;A61P3/04;A61P3/10;A61P43/00;C07D213/75;C07D231/40;C07D237/20;C07D239/42;C07D241/20;C07D249/04;C07D261/14;C07D271/06;C07D271/07;C07D275/02;C07D275/03;C07D277/18;C07D277/46;C07D277/60;C07D277/82;C07D285/08;C07D285/10;C07D285/12;C07D285/135;C07D401/12;C07D405/14;C07D413/12;C07D417/12;C07D417/14;C07D513/04 主分类号 A61K31/44
代理机构 代理人
主权项
地址